Gary K. Lee Lyell Immunopharma, Inc. (LYEL) insider trading activity
Gary K. Lee is Chief Scientific Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 176,696 shares of LYEL, which is worth approximately $95,415. The most recent transaction as insider was on Feb 10, 2025, when has been sold 112,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
177K
235.29%
3M change
235.29%
12M change
Total Value Held
$95,415
GKL
Gary K. Lee
Chief Scientific Officer
South San Francisco, CA